Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

FANCM and breast cancer risk

Mutations in several genes, including components of the Fanconi anemia DNA repair pathway, have been implicated in familial breast cancer risk, but much of the underlying genetic architecture remains unknown. A study by Heli Nevanlinna and colleagues (Proc. Natl. Acad. Sci. USA doi:10.1073/pnas.1407909111; 6 October 2014) now reports the discovery of an association between a variant in FANCM and breast cancer risk in the Finnish population. To identify new susceptibility genes, the authors performed exome sequencing on 24 patients with breast cancer from 11 Finnish families without mutations in BRCA1 or BRCA2. After applying several filters, they further prioritized variants in DNA repair genes and genotyped the most promising candidate risk variants in two large collections of breast cancer cases and controls from the Helsinki and Tampere regions of Finland. In a combined analysis of all data sets, they identified a nonsense variant in FANCM (encoding p.Gln1701*) that was associated with a two-fold increase in risk of breast cancer (P = 0.0018). This variant shows strongest association with triple-negative breast cancer and is present at a frequency of 1–2% in the Finnish population. Although the variant is rare in other populations, this finding suggests that distinct FANCM variants might contribute to breast cancer risk in different populations.


Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Vogan, K. FANCM and breast cancer risk. Nat Genet 46, 1159 (2014).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing